230 related articles for article (PubMed ID: 38350915)
1. Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data.
Mirian C; Thastrup M; Mathiasen R; Schmiegelow K; Olsen JV; Østergaard O
Fluids Barriers CNS; 2024 Feb; 21(1):14. PubMed ID: 38350915
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry-based proteomic techniques to identify cerebrospinal fluid biomarkers for diagnosing suspected central nervous system infections. A systematic review.
Bharucha T; Gangadharan B; Kumar A; de Lamballerie X; Newton PN; Winterberg M; Dubot-Pérès A; Zitzmann N
J Infect; 2019 Nov; 79(5):407-418. PubMed ID: 31404562
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
[TBL] [Abstract][Full Text] [Related]
4. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.
Samuel N; Remke M; Rutka JT; Raught B; Malkin D
J Neurooncol; 2014 Jun; 118(2):225-238. PubMed ID: 24771250
[TBL] [Abstract][Full Text] [Related]
6. Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4113-4126. PubMed ID: 30124047
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. The human CSF pain proteome.
Khoonsari PE; Ossipova E; Lengqvist J; Svensson CI; Kosek E; Kadetoff D; Jakobsson PJ; Kultima K; Lampa J
J Proteomics; 2019 Jan; 190():67-76. PubMed ID: 29852297
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
[TBL] [Abstract][Full Text] [Related]
10. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.
Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R
Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomic characterization of microvesicles/exosomes from the cerebrospinal fluid of patients with acute bilirubin encephalopathy.
Tan N; Hu S; Hu Z; Wu Z; Wang B
Mol Med Rep; 2020 Aug; 22(2):1257-1268. PubMed ID: 32468033
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients-immune-related candidate proteins affected by TNF blocking treatment.
Estelius J; Lengqvist J; Ossipova E; Idborg H; Le Maître E; Andersson MLA; Brundin L; Khademi M; Svenungsson E; Jakobsson PJ; Lampa J
Arthritis Res Ther; 2019 Feb; 21(1):60. PubMed ID: 30770760
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review.
Lehner KR; Jiang K; Rincon-Torroella J; Perera R; Bettegowda C
Neoplasia; 2023 Jan; 35():100852. PubMed ID: 36516487
[TBL] [Abstract][Full Text] [Related]
15. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study.
Rajagopal MU; Hathout Y; MacDonald TJ; Kieran MW; Gururangan S; Blaney SM; Phillips P; Packer R; Gordish-Dressman H; Rood BR
Proteomics; 2011 Mar; 11(5):935-43. PubMed ID: 21271676
[TBL] [Abstract][Full Text] [Related]
17. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease.
Modeste ES; Ping L; Watson CM; Duong DM; Dammer EB; Johnson ECB; Roberts BR; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2023 Jul; 18(1):48. PubMed ID: 37468915
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
[TBL] [Abstract][Full Text] [Related]
20. Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis.
Müller HL; Oh Y; Gargosky SE; Lehrnbecher T; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Nov; 77(5):1113-9. PubMed ID: 7521338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]